Schilddrüsenfunktion unter Selen-Substitution bei Patienten mit Koronarchirurgischen Eingriffen unter Einsatz der extrakorporalen Zirkulation
The postoperative period is associated with the biochemical features of Non-Thyroidal-Illness (NTI). Usually, there is a marked decrease of T3 due to a decreased 5`dejodinase (a selenoprotein) activity. Few studies have shown that selenium (Se) substitution may alter the low T3-state in severely ill patients. However, there are no data evaluating Se-substitution in the postoperative state. Therefore, we investigated prospectively the effect of parenteral selenium substitution in patients undergoing CPB. 20 patients received 500µg selenium i.v. as a bolus and 1000µg Se i.v./24h from the immediate postoperative period up to 4 days. 23 patients served as a control group. Selenium administration was associated with an increase in serum selenium-concentrations to the upper normal limit. Throughout the observation period (mean serum selenium concentrations ±SD increased from 0,60±0,28µmol/l to 1,29±0,15 µmol/l).Whereas patients in the control group were well below normal limits (below 0,71±0,36µmol/l; p<0,01 controls vs. Se-group). However, glutathione peroxidase activity (GPx) was not significancy different from the controls (2,92±1,7 vs. 1,34±0,4 nmol NADPH/min/mg day 4 postoperative). T3 levels after surgery were not altered by the Se administration (T3 Se-group 1,26±0,30 nmol/l vs. T3 controls 1,08±0,27 nmol/l on day 1 after CPB). Also TSH, T4, fT4 and rT3 were not influenced by selenium. Moreover, there was no difference in mortality and postoperative cardiac parameters in either group. In conclusion: Selenium administration to levels in the upper normal range was not associated with alterations in the severity of NTI during the postoperative period after CPB.
Share and cite
Could not load citation form. Default citation form is displayed.
Use and reproduction:
All rights reserved